Please note that this webinar was recorded in 2016. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.

AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.

This collection will give you access to the recordings of the presentations (listed below) and pdf slides only. CME/CMLE or SAM is not available for this collection


Description:

Did you miss out on joining us in Charlotte for the AMP 2016 Annual Meeting? Were you there but missed something you really wanted to see? We have you covered with the AMP 2016 Annual Meeting Highlights. Select presentations were recorded and are now available for online viewing.

 

CHIPping Away at the Mysteries of Hematopoiesis: The Science and Clinical Implications of Clonal Hematopoiesis of Indeterminate Potential

The concept of a pre-cancer¯ clonal proliferation is fundamental to our understanding of the natural evolution of a variety of cancer types and an active area of research. Recent recognition of pre-malignant clonal hematopoiesis has been yet another exciting discovery in this area. The speakers will discuss their work in identifying Clonal Hematopoiesis of Indeterminate Potential (CHIP) and its relationship to both aging and the subsequent development of recognized hematopoietic malignancies.

- Explain the concept of clonal hematopoiesis.

- Describe how clonal hematopoiesis can be evaluated using markers identified by high-through sequencing.

- Summarize current knowledge regarding the association between clonal hematopoiesis and the development of recognized hematopoietic cancers, particularly myelodysplastic syndromes.

 

Clonal Hematopoiesis of Indeterminate Potential

Benjamin Ebert, MD, PhD, Brigham and Women's Hospital

CHIP, ICUS, MDS: A Clinical Perspective

David P. Steensma, MD, Dana-Farber Cancer Institute, Boston, MA, USA

 

Duration1.5 hr

Recording Date: November 10, 2016


You might also be interested in:

Note: Join the AMP Family to purchase this content for a deep discount!

 

Course Information
Course Date:
November 10, 2016
CHIPping Away at the Mysteries of Hematopoiesis: The Science and Clinical Implications of Clonal Hematopoiesis of Indeterminate Potential
Individual topic purchase: Selected
Products
AMP 2016 Highlights - Ebert & Steensma
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $0.00